Tel Aviv University
Physiologically linked systems enhance preclinical drug testing, say Harvard-TAU researchers
The U.S. Food and Drug Administration (FDA) approves only 13.8% of all tested drugs, and these numbers are even lower in “orphan” diseases that affect relatively few people.
Part of the problem lies in the imperfect nature of preclinical drug testing that aims to exclude toxic effects and predetermine concentrations and administration routes before drug candidates can be tested in people. How new drugs move within the human body and are affected by it, and how drugs affect the body itself, cannot be predicted accurately enough in animal and standard in vitro studies.
“To solve this massive preclinical bottleneck problem, we need to become much more effective at setting the stage for drugs that are truly promising and rule out others that for various reasons are likely to fail in people,” explains Prof. Donald Ingber, M.D., Ph.D., founding director of Harvard University’s Wyss Institute for Biologically Inspired Engineering, co-author of two new studies on the subject published in Nature Biomedical Engineering on January 27, 2020.
Co-led by Dr. Ben Maoz of Tel Aviv University‘s Department of Biomedical Engineering and Sagol School of Neuroscience and over 50 colleagues, a team of scientists at TAU and Harvard have now devised a functioning comprehensive multi-Organ-on-a-Chip (Organ Chip) platform that enables effective in-vitro-to-in-vivo translation (IVIVT) of human drug pharmacology.
“We hope that this platform will enable us to bridge the gap on current limitations in drug development by providing a practical, reliable, relevant system for testing drugs for human use,” says Dr. Maoz, co-first author of both studies and former Technology Development Fellow at the Wyss Institute on the teams of Prof. Ingber and Prof. Kevin Kit Parker, Ph.D., the latter of whom is also a leading author of both studies.
In the first of two studies, the scientists developed the “Interrogator,” a robotic liquid transfer device to link individual “Organ Chips” in a way that mimics the flow of blood between organs in the human body.
Organ Chips are microfluidic devices composed of a clear flexible polymer the size of a computer memory stick that contains two parallel running hollow channels separated by a porous membrane and independently perfused with cell type-specific media. While one of the channels, the parenchymal channel, is lined with cells from a specific human organ or functional organ structure, the other one is lined with vascular endothelial cells presenting a blood vessel. The membrane allows the two compartments to communicate with each other and to exchange molecules like cytokines and growth factors, as well as drugs and drug products generated by organ-specific metabolic activities.
The team then applied their Interrogator automated linking platform and a new computational model they developed to three linked organs to test two drugs: nicotine and cisplatin.
“The modularity of our approach and availability of multiple validated Organ Chips for a variety of tissues for other human Body-on-Chip approaches now allows us to develop strategies to make realistic predictions about the pharmacology of drugs much more broadly,” says Prof. Ingber. “Its future use could greatly increase the success rates of Phase I clinical trials.”
The researchers accurately modeled the oral uptake of nicotine and intravenous uptake of cisplatin, a common chemotherapy medication, and their first passage through relevant organs with highly quantitative predictions of human pharmacokinetic and pharmacodynamic parameters.
“The resulting calculated maximum nicotine concentrations, the time needed for nicotine to reach the different tissue compartments, and the clearance rates in the Liver Chips in our in vitro-based in silico model mirrored closely what had been measured in patients,” concludes Dr. Maoz.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- The Doctor Is in (the Kitchen): Health & Wellness Books 2020on February 21, 2020 at 4:12 pm
In pursuit of the perfect chocolate chip cookie to serve the internet, writer and recipe developer Lindsay Maitland Hunt once baked 900 cookies in three months. “I was just so obsessed,” she says. So ...
- Microfluidic modeling of bone marrow pathophysiologyon February 19, 2020 at 12:35 pm
Chou et al. developed a human microfluidics-based organ-on-chip system to study how bone marrow injury and a rare genetic disorder affect hematopoietic cell function. This three-dimensional (3D) ...
- Researchers Push the Boundaries of Neuromorphics With Retina-inspired UV Sensoron February 17, 2020 at 5:37 pm
Another instance is "organs-on-a-chip" or chips capable of recreating core physiological functions. The researchers who discovered the retina-inspired photonic synapse launched the project as a ...
- Hammond Organ Sends Messages Which Can Be Decoded By A Spectrogramon February 16, 2020 at 4:00 pm
An Arduino was connected to the organ via a UNL2003 darlington array chip. This chip is driving some reed relays which make the organ connections to create the sine wave tones. With that hardware ...
- Explosion Of Interest In Organ-On-A-Chip Technologyon February 16, 2020 at 4:00 pm
November 25, 2019 | Organ-on-a-chip models were practically nonexistent a decade ago, but significant advances are now being made every few months. Among the many challenges facing researchers in the ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Human Body-on-chip Systems Improve Drug Testingon January 28, 2020 at 2:13 pm
New comprehensive multi-organ-on-a-Chip (Organ Chip) platform helps in effective in-vitro-to-in-vivo translation (IVIVT) of human drug pharmacology. The U.S. Food and Drug Administration (FDA ...
- TAU studies test drug effects with multi-Organ-on-a-Chip platformon January 28, 2020 at 11:06 am
Fifty scientists from Tel Aviv University and Harvard University published two studies in Nature Biomedical Engineering on Monday describing their invention of a functioning multi-Organ-on-a-Chip ...
- Organ-on-a-Chip aims to push through drug approvalson January 28, 2020 at 1:45 am
Researchers in Israel and the US have developed a multi-Organ-on-a-Chip that is claimed to overcome bottlenecks that hinder the development and approval of medicines. Preclinical drug testing aims to ...
- Improving drug testing with comprehensive 'Organ Chip' platformon January 27, 2020 at 12:38 pm
a team of scientists at TAU and Harvard have now devised a functioning comprehensive multi-Organ-on-a-Chip (Organ Chip) platform that enables effective in-vitro-to-in-vivo translation (IVIVT ...
- Enhancing drug testing with human body-on-chip systemson January 27, 2020 at 11:42 am
Scientists have devised a functioning comprehensive multi-Organ-on-a-Chip (Organ Chip) platform that enables effective preclinical drug testing of human drug pharmacology. The U.S. Food and Drug ...